Chronic Lymphocytic Leukemia Market Size to Reach US$ 17.17 Bn by 2029, Growing at a CAGR of 12.7% Summary The global Chronic Lymphocytic Leukemia (CLL) market is projected to grow significantly, reaching US$ 17.17 billion by 2029, with a compound annual growth rate (CAGR) of 12.7%. This growth is driven by advances in treatment options and an increase in the prevalence of CLL cases...